Targeted conversion of the transthyretin gene in vitro and in vivo.
about
Liver-targeted gene therapy: Approaches and challengesTherapeutic potential of RNA interference against cancerRecent progress in the understanding and treatment of transthyretin amyloidosis.Recent advances in transthyretin amyloidosis therapyModified bases enable high-efficiency oligonucleotide-mediated allelic replacement via mismatch repair evasion.Applications of gene therapy for familial amyloidotic polyneuropathy.Gene therapy progress and prospects: targeted gene repair.Gene editing technology as an approach to the treatment of liver diseases.Site-specific base changes in the coding or promoter region of the human beta- and gamma-globin genes by single-stranded oligonucleotides.Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis.Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina.Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model.Effects of atelocollagen formulation containing oligonucleotide on endothelial permeability.Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.Familial and Senile Amyloidosis Caused by TransthyretinAbstractsTherapy of ATTR amyloidosis: perspectiveProgression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation
P2860
Q28085748-315E0C4A-F4B4-4315-885B-8B4343092AA8Q28253746-49B5E194-3D28-412D-948A-871E88FC7AE1Q34416193-57CE8984-4316-4DE0-B3EA-EBCA0BB9CA5AQ34664696-F6D0B08A-4DDF-4E8E-B309-842D2EB2DAAEQ35198341-A2343B7E-9D69-46AF-9F74-B4BBBC3B2753Q35907026-3CA2582D-F058-459E-90C7-1440E6B52077Q36091278-6FEE16B3-602B-42A6-B79E-2614EC2118C5Q38749884-6E938746-9F03-41B7-BA4D-E0D713777E4FQ40435624-10AC6202-9C24-4221-A5E3-EF923DCCEC84Q41822889-AAFBAB26-6E35-4889-BFF9-5DDCCFD6EC94Q41967044-42EB98B3-EA91-4121-AD02-3157521C6967Q42185147-581A6A36-E8ED-402B-960A-0651F3649164Q42566793-7EEB8471-6A31-4B12-B429-FA00E8C965B4Q47140538-FFF29A06-047A-450F-B786-8CD3FD52498FQ47404960-45CC783F-F29F-45C1-880D-77A6999D7E2BQ48913743-8CAEB840-9BCA-408A-BBA8-F69F89172C62Q56031907-9BB4A7EE-2022-46DD-9DC8-2FAC4001EA32Q57259399-5E507FA9-E421-4E5D-96C1-38920348B632Q58125141-B8BB7AB7-ECA2-4397-B2CB-573E03FA341DQ58278688-DDA911D4-C32D-470F-893C-AB10D90DC42C
P2860
Targeted conversion of the transthyretin gene in vitro and in vivo.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Targeted conversion of the transthyretin gene in vitro and in vivo.
@en
Targeted conversion of the transthyretin gene in vitro and in vivo.
@nl
type
label
Targeted conversion of the transthyretin gene in vitro and in vivo.
@en
Targeted conversion of the transthyretin gene in vitro and in vivo.
@nl
prefLabel
Targeted conversion of the transthyretin gene in vitro and in vivo.
@en
Targeted conversion of the transthyretin gene in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Targeted conversion of the transthyretin gene in vitro and in vivo
@en
P2093
Nagahara S
Nakamura M
Tanihara H
Terazaki H
P2860
P2888
P304
P356
10.1038/SJ.GT.3302228
P50
P577
2004-05-01T00:00:00Z
P5875
P6179
1046870045